Skip to main content

2017 | OriginalPaper | Buchkapitel

17. Neurotoxizität

verfasst von : PD Dr. med. K. Oechsle, BSN RN Fachexpertin Onkologiepflege A. Margulies

Erschienen in: Onkologische Krankenpflege

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Wenn die Behandlung maligner Erkrankungen zu einer Langzeitremission bzw. zu einer Heilung führt, können Langzeitnebenwirkungen wie die Neurotoxizität die Lebensqualität des Patienten wesentlich beeinträchtigen. Die Pflegenden können durch gute Beobachtung und Beratung dazu beitragen, dass neurologische Symptome frühzeitig erkannt, medizinische Maßnahmen dadurch rechtzeitig eingeleitet und so lang anhaltende Neurotoxizitäten vermieden oder vermindert werden. Kommt es dennoch zu irreversiblen neurologischen Schäden, können gezielte pflegerische Interventionen und Zusammenarbeit mit anderen Diziplinen, z. B. Physiotherapie, Ergotherapie, den Patienten die Aufrechterhaltung von möglichst vielen Aktivitäten ermöglichen
Literatur
Zurück zum Zitat Christie LA et al. (2012) Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapie. Clin Cancer Res;18: 1954–65 Christie LA et al. (2012) Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapie. Clin Cancer Res;18: 1954–65
Zurück zum Zitat Hershman DL et al. (2014) Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 32(18):1941-67. doi: 10.1200/JCO.2013.54.0914 Hershman DL et al. (2014) Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 32(18):1941-67. doi: 10.​1200/​JCO.​2013.​54.​0914
Zurück zum Zitat Hershman DL et al. (2013) Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol 10; 31(20): 2627–33 Hershman DL et al. (2013) Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol 10; 31(20): 2627–33
Zurück zum Zitat Koeppen S (2009) Tumortherapiebedingte Neuropathie. Onkologe 15: 142–149 Koeppen S (2009) Tumortherapiebedingte Neuropathie. Onkologe 15: 142–149
Zurück zum Zitat Loprinzi CL et al. (2014) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J Clin Oncol 32: 997–1005 Loprinzi CL et al. (2014) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J Clin Oncol 32: 997–1005
Zurück zum Zitat Lavoie Smith EM et al. (2008) The total neuropathy score: a tool for measuring chemotherapy-induced peripehral neuropathy. Oncol Nurs Forum 35, 1: 96–102 Lavoie Smith EM et al. (2008) The total neuropathy score: a tool for measuring chemotherapy-induced peripehral neuropathy. Oncol Nurs Forum 35, 1: 96–102
Zurück zum Zitat Miltenburg NC, Boogerd W (2014) Chemotherapy-induced neuropathy: A comprehensive survey. Cancer Treat Rev 40: 872–82 Miltenburg NC, Boogerd W (2014) Chemotherapy-induced neuropathy: A comprehensive survey. Cancer Treat Rev 40: 872–82
Zurück zum Zitat Paice J (2009) Clinical Challenges: Chemotherapy-Induced Peripheral Neuropathy Seminars in Oncology Nursing, Vol 25, No 2, Suppl 1: S8–S19 Paice J (2009) Clinical Challenges: Chemotherapy-Induced Peripheral Neuropathy Seminars in Oncology Nursing, Vol 25, No 2, Suppl 1: S8–S19
Zurück zum Zitat Smith EM et al. (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. Apr 3; 309(13): 1359-67. doi: 10.1001/jama.2013.2813 Smith EM et al. (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. Apr 3; 309(13): 1359-67. doi: 10.​1001/​jama.​2013.​2813
Zurück zum Zitat Tofthagen C et al. (2013) Chemotherapy-Induced Peripheral Neuropathy:An Algorithm to Guide Nursing Management Clinical Journal of Oncology Nursing Volume 17; 2: 138–144 Tofthagen C et al. (2013) Chemotherapy-Induced Peripheral Neuropathy:An Algorithm to Guide Nursing Management Clinical Journal of Oncology Nursing Volume 17; 2: 138–144
Zurück zum Zitat Vardy J et al. (2014) Cognitive function and fatigue after diagnosis of colorectal cancer Ann. Onc 25: 2404–2412 Vardy J et al. (2014) Cognitive function and fatigue after diagnosis of colorectal cancer Ann. Onc 25: 2404–2412
Zurück zum Zitat Visovsky C et al. (2007) Putting evidence into practice: evidence based interventions for chemotherapy-induced peripheral neuropathy. Clin J Onc Nurs 11; 6: 901–913 Visovsky C et al. (2007) Putting evidence into practice: evidence based interventions for chemotherapy-induced peripheral neuropathy. Clin J Onc Nurs 11; 6: 901–913
Zurück zum Zitat Von Ah D (2015) Cognitive Changes Associated with Cancer Treatment: State of the Science. CJON Vol 19, Number 1: 1–10 Von Ah D (2015) Cognitive Changes Associated with Cancer Treatment: State of the Science. CJON Vol 19, Number 1: 1–10
Zurück zum Zitat Wickham R (2007) Chemotherapy induced peripher neuropathy – a review and implications for oncology nursing practice. Clin J Oncol Nurs 11; 3: 361–376 Wickham R (2007) Chemotherapy induced peripher neuropathy – a review and implications for oncology nursing practice. Clin J Oncol Nurs 11; 3: 361–376
Zurück zum Zitat Wolf S et al. (2008) Chemotherapy-induced peripheral neuropathy: Prevention and treatment stategies. Eur J Cancer 44: 1507–1515 Wolf S et al. (2008) Chemotherapy-induced peripheral neuropathy: Prevention and treatment stategies. Eur J Cancer 44: 1507–1515
Zurück zum Zitat Albers JW et al. (2014). Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database of Systematic Reviews (Online), March 2014 CD005228. DOI: 10.1002/14651858.CD005228.pub4 Albers JW et al. (2014). Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database of Systematic Reviews (Online), March 2014 CD005228. DOI: 10.​1002/​14651858.​CD005228.​pub4
Zurück zum Zitat Bender C, Thelen B (2013) Cancer and Cognitive Changes: The complexity of the Problem. Seminars in Oncology Nursing 29; 4: 232–237 Bender C, Thelen B (2013) Cancer and Cognitive Changes: The complexity of the Problem. Seminars in Oncology Nursing 29; 4: 232–237
Zurück zum Zitat Cavaletti G (2013) The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Annals of Oncology 24: 454–462, 2013 doi:10.1093/annonc/mds329 Cavaletti G (2013) The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Annals of Oncology 24: 454–462, 2013 doi:10.​1093/​annonc/​mds329
Zurück zum Zitat Dietrich J et al. (2008) Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist; 13: 1285–1295 Dietrich J et al. (2008) Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist; 13: 1285–1295
Zurück zum Zitat Frisina RD et al. (2016) Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-BasedChemotherapy in Survivors of Adult-Onset Cancer. J Clin Oncol. 10; 34(23): 2712–20 Frisina RD et al. (2016) Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-BasedChemotherapy in Survivors of Adult-Onset Cancer. J Clin Oncol. 10; 34(23): 2712–20
Zurück zum Zitat Grapp M, Argstatter H et al. (2014) Music therapy for chronic tinnitus: variability of tinnitus pitch in the course of therapy. J Am Acad Audiol 25(4): 335-42. doi: 10.3766/jaaa.25.4.5 Grapp M, Argstatter H et al. (2014) Music therapy for chronic tinnitus: variability of tinnitus pitch in the course of therapy. J Am Acad Audiol 25(4): 335-42. doi: 10.​3766/​jaaa.​25.​4.​5
Zurück zum Zitat Smith EM et al (2008), The Total Neuropathy Score: A Tool for Measuring Chemotherapy-Induced Peripheral Neuropathy. Oncology nursing Forum 35; 1: 96–102 Smith EM et al (2008), The Total Neuropathy Score: A Tool for Measuring Chemotherapy-Induced Peripheral Neuropathy. Oncology nursing Forum 35; 1: 96–102
Zurück zum Zitat Tzatha E, DeAngelis LM (2016) Chemotherapy-Induced Peripheral Neuropathy. Oncology 30(3): 240–4 Tzatha E, DeAngelis LM (2016) Chemotherapy-Induced Peripheral Neuropathy. Oncology 30(3): 240–4
Zurück zum Zitat Vasquez S (2014) Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice. Irish Journal of Medical Science 183; 1: 53–5 Vasquez S (2014) Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice. Irish Journal of Medical Science 183; 1: 53–5
Zurück zum Zitat Function Assessment of Chronic Illness Therapy: www.facit.org (Fragebogen zur Erfassung von Neurotoxizität, Fragebogen zur Erfassung der kognitiven Funktion) Function Assessment of Chronic Illness Therapy: www.​facit.​org (Fragebogen zur Erfassung von Neurotoxizität, Fragebogen zur Erfassung der kognitiven Funktion)
Metadaten
Titel
Neurotoxizität
verfasst von
PD Dr. med. K. Oechsle
BSN RN Fachexpertin Onkologiepflege A. Margulies
Copyright-Jahr
2017
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-662-53955-2_17